KR910020176A - 알도스 환원효소 저해제 - Google Patents

알도스 환원효소 저해제 Download PDF

Info

Publication number
KR910020176A
KR910020176A KR1019910008967A KR910008967A KR910020176A KR 910020176 A KR910020176 A KR 910020176A KR 1019910008967 A KR1019910008967 A KR 1019910008967A KR 910008967 A KR910008967 A KR 910008967A KR 910020176 A KR910020176 A KR 910020176A
Authority
KR
South Korea
Prior art keywords
compound
carbonyl
methylene
hydrogen
formula
Prior art date
Application number
KR1019910008967A
Other languages
English (en)
Inventor
다다시 요시다
도시유끼 가또
요시미 가와무라
고이찌 마쓰모또
히로시 이따자끼
Original Assignee
요시또시 가즈오
시오노기세이야꾸가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시또시 가즈오, 시오노기세이야꾸가부시끼가이샤 filed Critical 요시또시 가즈오
Publication of KR910020176A publication Critical patent/KR910020176A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

내용 없음

Description

알도스 환원효소 저해제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 본 발명의 RD―01―A4의 UV 스펙트럼이고, 제2도는 본 발명의 RD―01―A4의 IR 스펙트럼이고, 제3도는 본 발명의 RD―01―A4의1H―NMR 스펙트럼이다.

Claims (6)

  1. 하기 일반식 (A)의 화합물 또는 그의 염 :
    [식중, X는 메틸렌 또는 카르보닐이고, R은또는 R4이며, R1, R2, R3및 R4는 각각 수소 또는 저급알킬이다]
  2. 제1항에 있어서, X가 메틸렌일 때 R이또는,이고, X가 카르보닐일 때 R이 R4,또는인 화합물 또는 그의 염.
  3. 제1항에 있어서, R3또는 R4가 수소인 화합물 또는 그의 염.
  4. 하기 일반식 (B)의 화합물을 생성할 수 있는 크루시불룸(Crucibulum) sp. RF―3817 또는 그의 변이체를 배양하고, 배양 배지로부터 상기 화합물을 단리하고, 임의로 상기 화합물을 알킬화함을 특징으로 하는, 하기 일반식 (A)의 화합물의 제조방법.
    [식중, X가 메틸렌일때 R은또는,이고, X가 카르보닐일 때, R은 H,또는이다.]
    [식중, X는 메틸렌 또는 카르보닐이고, R은또는 R4이며, R1, R2, R3및 R4는 각각 수소 또는 저급알킬이다.]
  5. 유효 성분으로서 약학적으로 허용가능한 실제로 비독성인 담체 또는 부형제와 함께 하기 일반식 (A)의 화합물을 함유하는 약제:
    [식중, X는 메틸렌 또는 카르보닐이고, R은또는 R4이며, R1, R2, R3및 R4는 각각 수소 또는 저급알킬이다.]
  6. 제5항에 있어서, 알도스 환원 효소를 저해하는 약제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910008967A 1990-05-30 1991-05-30 알도스 환원효소 저해제 KR910020176A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14246390 1990-05-30
JP90-142463 1990-05-30

Publications (1)

Publication Number Publication Date
KR910020176A true KR910020176A (ko) 1991-12-19

Family

ID=15315903

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910008967A KR910020176A (ko) 1990-05-30 1991-05-30 알도스 환원효소 저해제

Country Status (9)

Country Link
US (1) US5324742A (ko)
EP (1) EP0459449B1 (ko)
JP (1) JPH04217684A (ko)
KR (1) KR910020176A (ko)
AT (1) ATE115956T1 (ko)
DE (1) DE69106047T2 (ko)
DK (1) DK0459449T3 (ko)
ES (1) ES2069118T3 (ko)
GR (1) GR3014909T3 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011045330A1 (en) 2009-10-13 2011-04-21 Tibotec Pharmaceuticals Macrocyclic integrase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU163443B (ko) * 1970-08-26 1973-08-28
US4337265A (en) * 1981-08-21 1982-06-29 Ayerst, Mckenna & Harrison Inc. Cyclohepta[b]pyrrole derivatives
US4503236A (en) * 1982-04-19 1985-03-05 Warner-Lambert Company Antiallergic 4Hfuro[3,2-b]indoles
FR2533563A1 (fr) * 1982-09-23 1984-03-30 Adir Nouveaux derives de la sulfonyluree, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
HU203350B (en) * 1984-08-24 1991-07-29 Pfizer Process for producing antiinflammatory tricyclic oxindole derivatives
IL80475A (en) * 1985-11-07 1993-01-31 Pfizer Heterocyclic-substituted 4-oxo (or thio)-3h- phthalazinyl-acetic acid derivatives and pharmaceutical compositions containing them
WO1993012786A1 (en) * 1986-07-10 1993-07-08 Howard Harry R Jr Indolinone derivatives

Also Published As

Publication number Publication date
GR3014909T3 (en) 1995-05-31
EP0459449B1 (en) 1994-12-21
DE69106047T2 (de) 1995-06-22
DK0459449T3 (da) 1995-02-20
JPH04217684A (ja) 1992-08-07
US5324742A (en) 1994-06-28
ATE115956T1 (de) 1995-01-15
ES2069118T3 (es) 1995-05-01
DE69106047D1 (de) 1995-02-02
EP0459449A1 (en) 1991-12-04

Similar Documents

Publication Publication Date Title
ATE302001T1 (de) Stabilisierte askorbinsäurederivate
FI940788A (fi) Alkoholi- tai aldehydijohdannaiset ja niiden käyttö
PT96324A (pt) Processo para a preparacao de compostos peptidicos e de composicoes farmaceuticas que os contem
KR890701557A (ko) 리폭시게나제 억제화합물을 함유하는 푸란 및 피롤
ATE316967T1 (de) Zyklische amidderivate die cathepsin k hemmen
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
EA200100994A1 (ru) 1-АМИНОТРИАЗОЛО[4,3-а]ХИНАЗОЛИН-5-ОНЫ И/ИЛИ -5-ТИОНЫ, ИНГИБИРУЮЩИЕ ФОСФОДИЭСТЕРАЗУ-IV
MX7096E (es) Metodo para preparacion de derivados de 2-oxoazetidina
AU2001269540A1 (en) Serotonin reuptake inhibitors
SE8305160L (sv) Antibakteriella emnen
KR910020176A (ko) 알도스 환원효소 저해제
ATE146476T1 (de) Cephalosporinverbindungen und verfahren zu ihrer herstellung
AR001767A1 (es) Derivados de ciclolignanos utiles como inmunosupresores composiciones farmaceuticas que los contienen y procedimiento para preparar dichos derivados
CA2377233A1 (en) Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
DK0504290T3 (da) Inhibitorer af dihydrofylatreduktase fra Pneumocystis carinii
BR9611789A (pt) Processo para a preparação de derivados de ácido metoximino-fenilglioxílico
PL348919A1 (en) Method for preparing bicyclic compounds and use of said method for preparing an interleukin-1$g(b) conversion enzyme (ice) inhibitor
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
MA25495A1 (fr) Compositions contenant des esters pour traiter les infestations parasitiques d'organismes
KR970027083A (ko) 페넴 유도체 및 이의 제조방법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid